The American College of Cardiology, the American Heart Association, and the Heart Failure Society of America published the guidelines in various journals April 1. The new guidelines revise original stages of heart failure, from A-D, to identify heart failure risk factors early. The treatment strategies for symptomatic patients were updated to include SGLT-2 inhibitor medications.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
